Works matching IS 03407004 AND DT 2018 AND VI 67 AND IP 1
Results: 15
The STAT3 inhibitor pyrimethamine displays anti-cancer and immune stimulatory effects in murine models of breast cancer.
- Published in:
- Cancer Immunology, Immunotherapy, 2018, v. 67, n. 1, p. 13, doi. 10.1007/s00262-017-2057-0
- By:
- Publication type:
- Article
Administration of low-dose combination anti-CTLA4, anti-CD137, and anti-OX40 into murine tumor or proximal to the tumor draining lymph node induces systemic tumor regression.
- Published in:
- Cancer Immunology, Immunotherapy, 2018, v. 67, n. 1, p. 47, doi. 10.1007/s00262-017-2059-y
- By:
- Publication type:
- Article
Immunological classification of renal cell carcinoma patients based on phenotypic analysis of immune check-point molecules.
- Published in:
- Cancer Immunology, Immunotherapy, 2018, v. 67, n. 1, p. 113, doi. 10.1007/s00262-017-2060-5
- By:
- Publication type:
- Article
Tumor infiltrating lymphocytes in lymph node metastases of stage III melanoma correspond to response and survival in nine patients treated with ipilimumab at the time of stage IV disease.
- Published in:
- Cancer Immunology, Immunotherapy, 2018, v. 67, n. 1, p. 39, doi. 10.1007/s00262-017-2061-4
- By:
- Publication type:
- Article
Bile duct obstruction in a patient treated with nivolumab as second-line chemotherapy for advanced non-small-cell lung cancer: a case report.
- Published in:
- Cancer Immunology, Immunotherapy, 2018, v. 67, n. 1, p. 61, doi. 10.1007/s00262-017-2062-3
- By:
- Publication type:
- Article
Monitoring the response of urothelial precancerous lesions to Bacillus Calmette-Guerin at the proteome level in an in vivo rat model.
- Published in:
- Cancer Immunology, Immunotherapy, 2018, v. 67, n. 1, p. 67, doi. 10.1007/s00262-017-2063-2
- By:
- Publication type:
- Article
HLA class I expression predicts prognosis and therapeutic benefits from tyrosine kinase inhibitors in metastatic renal-cell carcinoma patients.
- Published in:
- Cancer Immunology, Immunotherapy, 2018, v. 67, n. 1, p. 79, doi. 10.1007/s00262-017-2064-1
- By:
- Publication type:
- Article
Daunorubicin conjugated with alpha-fetoprotein selectively eliminates myeloid-derived suppressor cells (MDSCs) and inhibits experimental tumor growth.
- Published in:
- Cancer Immunology, Immunotherapy, 2018, v. 67, n. 1, p. 101, doi. 10.1007/s00262-017-2067-y
- By:
- Publication type:
- Article
Phase I/II trial of dendritic cell-based active cellular immunotherapy with DCVAC/PCa in patients with rising PSA after primary prostatectomy or salvage radiotherapy for the treatment of prostate cancer.
- Published in:
- Cancer Immunology, Immunotherapy, 2018, v. 67, n. 1, p. 89, doi. 10.1007/s00262-017-2068-x
- By:
- Publication type:
- Article
Ipilimumab and early signs of pulmonary toxicity in patients with metastastic melanoma: a prospective observational study.
- Published in:
- Cancer Immunology, Immunotherapy, 2018, v. 67, n. 1, p. 127, doi. 10.1007/s00262-017-2071-2
- By:
- Publication type:
- Article
Tumor-infiltrating immune cells as potential biomarkers predicting response to treatment and survival in patients with metastatic melanoma receiving ipilimumab therapy.
- Published in:
- Cancer Immunology, Immunotherapy, 2018, v. 67, n. 1, p. 141, doi. 10.1007/s00262-017-2072-1
- By:
- Publication type:
- Article
Quantification of altered tissue turnover in a liquid biopsy: a proposed precision medicine tool to assess chronic inflammation and desmoplasia associated with a pro-cancerous niche and response to immuno-therapeutic anti-tumor modalities.
- Published in:
- Cancer Immunology, Immunotherapy, 2018, v. 67, n. 1, p. 1, doi. 10.1007/s00262-017-2074-z
- By:
- Publication type:
- Article
Safety of shortened infusion times for combined ipilimumab and nivolumab.
- Published in:
- Cancer Immunology, Immunotherapy, 2018, v. 67, n. 1, p. 135, doi. 10.1007/s00262-017-2075-y
- By:
- Publication type:
- Article
Clinical grade manufacturing of genetically modified, CAR-expressing NK-92 cells for the treatment of ErbB2-positive malignancies.
- Published in:
- Cancer Immunology, Immunotherapy, 2018, v. 67, n. 1, p. 25, doi. 10.1007/s00262-017-2055-2
- By:
- Publication type:
- Article
2nd Symposium on Advances in Cancer Immunology and Immunotherapy, December 15-17, 2016, Athens, Greece.
- Published in:
- 2018
- By:
- Publication type:
- Report